🇺🇸 FDA
Patent

US 12214045

Multi-arm polymer conjugates of TLR agonist compounds and related immunotherapeutic treatment methods

granted A61KA61K47/54A61K47/60

Quick answer

US patent 12214045 (Multi-arm polymer conjugates of TLR agonist compounds and related immunotherapeutic treatment methods) held by Nektar Therapeutics expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Feb 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K47/54, A61K47/60, A61K47/642, A61K9/0029